Medical News

RSS

Tetraphase Pharmaceuticals presents preclinical data of TP-434 antibacterial drug

Tetraphase Pharmaceuticals, Inc., today presented encouraging preclinical data for its lead drug candidate, TP-434, which showed the potent antibacterial activity of TP-434 against a very broad spectrum of susceptible and multidrug-resistant pathogens.

16 Sep 2010

Researchers find clue behind ASD affecting males than females

New research from the Centre for Addiction and Mental Health (CAMH) and The Hospital for Sick Children (SickKids), both in Toronto, Canada provides further clues as to why Autism Spectrum Disorder (ASD) affects four times more males than females. The scientists discovered that males who carry specific alterations of DNA on the sole X-chromosome they carry are at high risk of developing ASD. The research is published in the September 15 issue of Science Translational Medicine.

16 Sep 2010

Community diabetes self-management education program helps Latinos with type 2 diabetes: Study

A diabetes self-management education program delivered by community health workers may be effective in improving the blood sugar levels and behavioral skills among Hispanics/Latinos with type 2 diabetes, according to a recent University of Illinois at Chicago study.

16 Sep 2010

NEB receives SBIR funding to develop novel enzymatic reagents for epigenetic studies

New England Biolabs (NEB) has announced that it has received fast track SBIR funding of $1.22 million to fund the research and development of novel enzymatic reagents for epigenetic studies.

From New England Biolabs 16 Sep 2010

Chimerix presents promising clinical data for CMX001 in late-breaker poster session at 50th ICAAC

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today presented promising clinical data for CMX001 in a late-breaker poster session at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.

16 Sep 2010

Angioslide commercializes Proteus device for ECA in the U.S.

Angioslide, Inc. of Minneapolis, MN and Angioslide, Ltd. Herzliya, Israel, announced today that the company has commercialized the Proteus device for Embolic Capture Angioplasty in the United States. The device combines an angioplasty balloon and embolic capture feature into one device, thus providing physicians with a simple and cost-effective method of capturing of embolic particles during angioplasty procedures.

16 Sep 2010

Aetna supports landmark study on BRCA testing

Testing is available to help identify if a woman is likely to face one of her gender's worst fears: inherited breast and ovarian cancer. But significant questions have been raised among doctors and public health agencies about whether these tests are being offered to the women who can most benefit - consistent with the evidence-based guidelines for this testing - and whether the information learned from testing is being put to best use.

16 Sep 2010

Researchers find NCT analogs show antimicrobial, anticoagulant activity

Catheter-related bacteremia can be a significant cause of sickness and death for hemodialysis patients. The anticoagulant heparin is commonly used as a catheter lock solution to prevent thrombosis; however has limited antimicrobial activity.

16 Sep 2010

Professor advocates steps to help health care industry increase patient understanding of health information

Studies show that nearly half of all Americans have difficulty understanding health information. Confusing medical directions, such as dosage and timing of prescription medicine, can lead to serious consequences including health setbacks, inappropriate hospital admissions and, sometimes, death. Now, researchers at the University of Missouri School of Health Professions are examining what health care facilities can do to increase patient understanding and positive outcomes.

16 Sep 2010

BCBC Consortium aims to develop cell-based therapy for insulin delivery

Oregon Health & Science University's Markus Grompe, M.D., will lead a multi-center team of scientists selected to participate in the prestigious Beta Cell Biology Consortium (BCBC). Funded by the National Institute of Diabetes and Digestive and Kidney Diseases, the consortium's long-term goal is to develop a cell-based therapy for insulin delivery in type 1 diabetes patients.

16 Sep 2010

ViroPharma presents Phase 1 study data of VP20621 at ICAAC 2010

ViroPharma Incorporated today announced the presentation of data from its Phase 1 study of VP20621 (non-toxigenic Clostridium difficile), a novel treatment approach for preventing recurrent Clostridium difficile infections, a common and dangerous gastrointestinal infection typically occurring in older adults after use of antibiotic medications.

16 Sep 2010

UCLA selected to help establish guidelines for health, safety of firefighters in the field

The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have been selected by the U.S. Department of Homeland Security's Science and Technology Directorate to help establish guidelines for the health and safety of firefighters in the field.

16 Sep 2010

New clinical trial supports benefits of turmeric extract to people with osteoarthritis

A new clinical trial supports the benefits to people with osteoarthritis who used a unique extract of turmeric. Scientists in Italy have studied the pain-relief, increased flexibility, and other effects of a special, patented extract of the roots of turmeric, the flavorful spice that has been used for centuries as a traditional remedy. Turmeric formulations have shown a wide range of safety and significant scientific and clinical benefits in recent animal research and human clinical trials.

16 Sep 2010

Researchers identify interferons may inhibit IL-1b protein production

Among the first is the production of cell factors such as interferons and IL-1beta. Interferons have several functions, including activating a series of intracellular signals such as Tyk2 (Tyrosine kinase 2), while IL-1beta is important for the induction of inflammation, which helps directly to protect the body against attack.

16 Sep 2010

Research suggests methodical approaches to control severe aggression among children with ADHD

Joseph C. Blader, Ph.D., Assistant Professor, Department of Psychiatry & Behavioral Science at Stony Brook University School of Medicine, and colleagues, found that almost half of children with attention-deficit/hyperactivity disorder whose aggressive behaviors had not been effectively controlled during routine outpatient care could achieve near absence of aggressive, explosive behavior when implementing "first-line" stimulant treatments for ADHD tailored to individual needs, along with behavioral therapy.

16 Sep 2010

Mild memory loss can indicate progressive dementia: Research

Simply getting older is not the cause of mild memory lapses often called senior moments, according to a new study by researchers at the Rush Alzheimer's Disease Center. The study, published in the September 15, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology, found that even the very early mild changes in memory that are much more common in old age than dementia are caused by the same brain lesions associated with Alzheimer's disease and other dementias.

16 Sep 2010

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.

16 Sep 2010

HHS awards grant to develop patient-centered outcomes research

U.S. Department of Health and Human Services (HHS) Assistant Secretary for Health, Howard K. Koh, MD, MPH, today announced the award of more than $14 million to develop, implement, and test strategies to increase the adoption and dissemination of interventions based on patient-centered outcomes research among racial and ethnic minority populations.

16 Sep 2010

Overprotection during childhood leads to heart-focused anxiety in adults with congenital heart disease: Study

Adults with congenital heart disease are more likely to suffer heart-focused anxiety - a fear of heart-related symptoms and sensations - if their parents were overprotective during their childhood and adolescence. Dr. Lephuong Ong from Orion Health Services in Vancouver, and colleagues from University Health Network and York University in Toronto, Canada, suggest that health care professionals could encourage greater independence for adolescents and adults with congenital heart disease to improve their psychosocial adjustment. Dr. Ong's work1 is published online in Springer's International Journal of Behavioral Medicine.

16 Sep 2010

Label reading is even more effective than exercise: Analysis

Diet and exercise have long been the top two elements of effective weight loss. Now add a third: reading the labels on packaged foods. Washington State University Economist Bidisha Mandal has found that middle-aged Americans who want to lose weight and who take up the label-reading habit are more likely to lose weight than those who don't. In some cases, label reading is even more effective than exercise.

16 Sep 2010

Medical News

Tetraphase Pharmaceuticals presents preclinical data of TP-434 antibacterial drug

Researchers find clue behind ASD affecting males than females

Community diabetes self-management education program helps Latinos with type 2 diabetes: Study

NEB receives SBIR funding to develop novel enzymatic reagents for epigenetic studies

Chimerix presents promising clinical data for CMX001 in late-breaker poster session at 50th ICAAC

Angioslide commercializes Proteus device for ECA in the U.S.

Aetna supports landmark study on BRCA testing

Researchers find NCT analogs show antimicrobial, anticoagulant activity

Professor advocates steps to help health care industry increase patient understanding of health information

BCBC Consortium aims to develop cell-based therapy for insulin delivery

ViroPharma presents Phase 1 study data of VP20621 at ICAAC 2010

UCLA selected to help establish guidelines for health, safety of firefighters in the field

New clinical trial supports benefits of turmeric extract to people with osteoarthritis

Researchers identify interferons may inhibit IL-1b protein production

Research suggests methodical approaches to control severe aggression among children with ADHD

Mild memory loss can indicate progressive dementia: Research

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

HHS awards grant to develop patient-centered outcomes research

Overprotection during childhood leads to heart-focused anxiety in adults with congenital heart disease: Study

Label reading is even more effective than exercise: Analysis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News